Credit Suisse Starts Enfusion Inc (ENFN) at Neutral
Tweet
Share
E-mailGet Alerts ENFN Hot Sheet
Price: $10.76 --0%
Rating Summary:
0 Buy, 6 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
0 Buy, 6 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Credit Suisse analyst Kevin McVeigh initiates coverage on Enfusion Inc (NYSE: ENFN) with a Neutral rating and a price target of $26.00.
For an analyst ratings summary and ratings history on Enfusion Inc click here. For more ratings news on Enfusion Inc click here.
Shares of Enfusion Inc closed at $22.94 yesterday.
You May Also Be Interested In
- DA Davidson Starts Everus (ECG) at Buy
- TD Cowen Assumes Incyte (INCY) at Buy
- TD Cowen Assumes Atara Biotherapeutics (ATRA) at Buy
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
